Despite industry-wide stock slump, Mass. biotech startups raised $5.1 billion in the first half of 2022

by Ashley Hayward | Aug 30, 2022 | In the Press

Boston Business Journal: MassBio report shows growing industry hampered by housing, transportation

by Ashley Hayward | Aug 30, 2022 | In the Press

Massachusetts biotech companies thrive during pandemic, report finds

by Ashley Hayward | Aug 30, 2022 | In the Press

The future of Boston office work is hybrid

by Ashley Hayward | Aug 26, 2022 | In the Press

Report: To expand, diversify biotech industry, look beyond the 4-year-degree

by Ashley Hayward | Jun 1, 2022 | In the Press

Massachusetts to compete for new federal “high risk-high reward” biomedical research agency

by Ashley Hayward | May 16, 2022 | In the Press